Boscalid belongs to FRAC Group 7 and is a succinate dehydrogenase inhibitor (SDHI) that disrupts the normal energy metabolism of pathogens by inhibiting complex II of the mitochondrial respiratory chain.
This active ingredient exhibits protective and some early curative activity against certain susceptible fungal diseases.
In agricultural applications, Boscalid can be used to manage certain gray mold diseases caused by Botrytis, Alternaria-related leaf spot diseases, and other locally registered diseases.
Boscalid can be developed as a single-active-ingredient formulation or formulated in combination with fungicides that have different modes of action.
For example, the combination of Boscalid and Pyraclostrobin belongs to FRAC Group 7 + 11 and has a different formulation positioning compared to standalone Boscalid products.
It should be noted that some pathogens, such as those causing gray mold, have already shown reduced susceptibility to SDHI fungicides; therefore, product application should be guided by local resistance data.
Importers should focus on target pathogens, product formulation quality, and the market usage of local SDHI products.
Supply Information
MaFa Agro provides supply consulting for Boscalid-related products and can coordinate formulation specifications, package sizes, brand labeling, and technical documentation according to customer needs.
We assist importers in confirming product quality documentation, sample requirements, and bulk purchase terms.